New York S 2387: Relates to investigating critical prescription drug pricing

Status: REFERRED TO INSURANCE (as of 2024-01-03)

State: New York · Session: 2023-2024 · Bill: S 2387

Sponsors: Zellnor Myrie

View New York S 2387 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.